NT, H., TL, M., J, K., J, T., & J, E. (2020). Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective. International journal of technology assessment in health care, 37, e28. https://doi.org/10.1017/S0266462320000823
Chicago Style (17th ed.) CitationNT, Hillock, Merlin TL, Karnon J, Turnidge J, and Eliott J. "Value Assessment of Antimicrobials and the Implications for Development, Access, and Funding of Effective Treatments: Australian Stakeholder Perspective." International Journal of Technology Assessment in Health Care 37 (2020): e28. https://doi.org/10.1017/S0266462320000823.
MLA (9th ed.) CitationNT, Hillock, et al. "Value Assessment of Antimicrobials and the Implications for Development, Access, and Funding of Effective Treatments: Australian Stakeholder Perspective." International Journal of Technology Assessment in Health Care, vol. 37, 2020, p. e28, https://doi.org/10.1017/S0266462320000823.